Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01070069 · ClinicalTrials.gov registry record · NA
Percutaneous Endovascular Aneurysm Repair (PEVAR) Trial
A NA study, sponsored by Endologix.
- Completed
- Registry status
- NA
- Development phase
- 192
- Enrollment target
NCT01070069: Completed NA study, sponsored by Endologix.
NCT01070069 is a NA study that has completed, run by Endologix. The registered enrollment target is 192 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01070069, a NA study, has completed, sponsored by Endologix.
- COMPLETED
- Registry status
- NA
- Development phase
- 192 participants
- Enrollment target
Study Summary
To determine the safety and effectiveness of PEVAR.
Primary Outcome
The primary endpoint for the trial is 30-day Treatment Success, defined as the composite of the following as determined by the independent physician adjudicator: * Procedural technical success * Absence of vascular complication * Absence of major adverse event
Interventions
- DEVICE PEVAR (ProGlide closure)
- DEVICE SEVAR (IntuiTrak)
- DEVICE PEVAR (Prostar XL closure)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 192 participants |
| Start Date | 2010-04-13 |
| Est. Completion | 2012-09-05 |
| Phase | NA |
What the finished NCT01070069 record still lists
NCT01070069 is an interventional study that assigns participants to a tested intervention. The registered 192 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 3 interventions - of which PEVAR (ProGlide closure) is the first listed.
NCT01070069 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01070069 about?
NCT01070069 is a clinical study titled "Percutaneous Endovascular Aneurysm Repair (PEVAR) Trial". To determine the safety and effectiveness of PEVAR.
What is the current status of trial NCT01070069?
This trial is currently completed. It is a NA study. The enrollment target is 192 participants. The study started on 2010-04-13. Estimated completion is 2012-09-05.
What interventions are being tested in trial NCT01070069?
The interventions under investigation include: PEVAR (ProGlide closure) (DEVICE), SEVAR (IntuiTrak) (DEVICE), PEVAR (Prostar XL closure) (DEVICE).
Who is sponsoring clinical trial NCT01070069?
This trial is sponsored by Endologix, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01070069's enrollment target sits among peer trials
192 570th of 2000 higher than 1,427 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01492972 · 192 participants · Phase 3
Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer
- NCT01973881 · 192 participants
Quantitative MRI for Myelofibrosis
- NCT02535702 · 192 participants · NA
Development Of Neuroimaging Methods To Assess The Neurobiology Of Addiction
- NCT03622359 · 192 participants · NA
Radiotracer-Based Perfusion Imaging of Patients With Peripheral Arterial Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI